Patient with bone marrow cancer takes part in ‘exciting’ drug trial
A patient with bone marrow cancer was able to join a research study offering the option of alternative drug treatment. The MajesTEC-9 study is looking at different drug options for multiple myeloma (MM) cancer. As part of the study, the patient was given a drug called Teclistamab, which is an antibody that binds to the… Read more »